SEI IDTA Early Identification and Treatment of Prenatally Exposed Infants

September 3, 2015
Sharon Burke, MD




Video below hosted on


See video




Early Identification and Treatment of Prenatally Exposed Infants 

Thursday, September 3, 2015 | 11-1:00 PM PT (12 PM MT, 1 PM CT, 2 PM ET)


The webinar will provide an opportunity for attendees to participate in a discussion on early identification of prenatally exposed infants at birth, definition of substance exposed infants across systems, and pharmacological and non-pharmacological treatment of infants with NAS.

Attendees for this webinar will include medical partners, specifically pediatricians, neonatologists, and others in the medical community who work closely with substance exposed infants at birth. We will have a portion of the time dedicated for Q&A with Dr. Burke and the SEI-IDTA sites.  

Dr. Sharon Burke, M.D. is the Clinical Director of the Infant Toddler Rehabilitation Program at PSE&G Children’s Specialized Hospital in New Brunswick, New Jersey where she joined in 1993. She is also clinical instructor in Pediatrics and Neonatology at Rutgers University Hospital and RWJMC. She did a pediatric internship and residency at NBIMC and Neonatal-Perinatal Fellowship at SPMC. From 1989-1993, Dr. Burke was the Clinical Director of the Neonatal Intensive Care Unit at University Hospital, Newark, NJ Dr. Burke graduated from Ross University School of Medicine in 1983. She has won several awards and honors for her work.




  • Sharon Burke, MD.